Bernard Golko

QVITI S.A.

About Presenter
Bernard Gołko is the CEO and co-founder of QVITI S.A., a Polish neurotechnology company developing dual-use neuromodulation solutions for civilian healthcare and military rehabilitation. He leads the company’s strategic development, clinical deployment programs, and international expansion, including collaborations with military medical centers in Poland and clinical research institutions in the United States (FDA pathway). His work focuses on applying non-invasive brain stimulation to accelerate recovery after stroke, TBI and PTSD, and to enhance cognitive resilience in high-stress operational environments.
Title of presentation
QVITI — Neurotechnology for Military Readiness & Civilian Rehabilitation
Focus Areas

Reimagining Healthcare: Access for All

Objective: Explore innovations making healthcare inclusive, affordable and impactful worldwide.

Introduction: the Problem

There is a growing need to support recovery from neurological and psychological conditions in both civilian healthcare and the military. Stroke, depression, PTSD and traumatic brain injury (TBI) affect millions of people, including soldiers exposed to high operational stress. Traditional rehabilitation is slow, resource-intensive and often insufficient.

QVITI develops and deploys non-invasive neuromodulation (tES) and neurorehabilitation solutions that enhance neuroplasticity, enabling faster and more effective recovery.

These technologies have a dual-use role:

  • Civilian: post-stroke and aphasia rehabilitation, depression, cognitive dysfunction.
  • Military: recovery after TBI and PTSD, reduction of phantom pain, and cognitive resilience training for high-load operators (e.g., drone/ISR units).


The project is already in implementation:

  • clinical deployments in Poland,
  • FDA-pathway research with U.S. centers,
  • introduction in a leading military medical hospital,
  • collaboration within dual-use and life science clusters.

Goal: create a scalable neurotechnology model that strengthens both national defense readiness and public health.

Collaboration Offer

We are looking to collaborate with clinical, military, research, and innovation partners who share the goal of improving neurological recovery and psychological resilience.

What we offer:

  • Access to certified neuromodulation systems (tES) and rehabilitation protocols.
  • Joint clinical implementation in hospitals and rehabilitation centers.
  • Participation in research projects (including FDA-pathway studies).
  • Co-development of therapy protocols for post-stroke, TBI, PTSD, and cognitive training.
  • Knowledge transfer and training for medical and military personnel.


What we are looking for:

  • Hospitals and military medical units interested in pilot deployment.
  • Research partners to expand clinical evidence and validation.
  • Strategic partners for international scaling.


How to get involved: A collaboration can begin with a pilot program, training workshop, or evaluation deployment adapted to local clinical or operational needs. Benefit for partners: You gain early access to proven dual-use neurotechnology, improved patient and soldier outcomes, reduced rehabilitation time, and the opportunity to shape next-generation protocols that can be adopted nationally and internationally. In short: Let’s build a shared model of neurorehabilitation that strengthens both public health and national resilience.